Verify_RP_ULcer

The chart shows the growth of an initial investment of $10,000 in Verify_RP_ULcer, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.

Based on dividend-adjusted daily data since Jan 12, 2024, Verify_RP_ULcer's average daily return is +0.12%, while the average monthly return is +2.43%. At this rate, your investment would double in approximately 2.4 years.

Historically, 71% of months were positive and 29% were negative. The best month was Sep 2024 with a return of +8.2%, while the worst month was Dec 2024 at -2.4%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 1 months.

On a daily basis, Verify_RP_ULcer closed higher 59% of trading days. The best single day was Apr 9, 2025 with a return of +7.4%, while the worst single day was Apr 4, 2025 at -6.6%.

Verify_RP_ULcer has an annualized alpha of 20.34%, beta of 0.80, and R² of 0.66 versus S&P 500 Index. Calculated based on daily prices since January 12, 2024.

• This portfolio captured 122.91% of S&P 500 Index gains and tended to rise during its downturns (downside capture of -9.66%) — a profile typical of hedging or uncorrelated assets.
• This portfolio generated an annualized alpha of 20.34% versus S&P 500 Index — delivering returns beyond what market exposure alone would predict.

Verify_RP_ULcer has an expense ratio of 0.01%, which is considered low. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.

Verify_RP_ULcer ranks 85 for risk / return — in the top 85% of portfolios on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Verify_RP_ULcer Sharpe ratios as of Apr 4, 2026 (values are recalculated daily):

• 1-Year: 1.96
• All Time: 2.23

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

Compared to the broad market, where average Sharpe ratios range from 0.99 to 1.69, this portfolio's current Sharpe ratio is in the top 25%. This signifies superior risk-adjusted performance, meaning the portfolio is delivering strong returns for the level of risk taken compared to most others.

The chart below shows the rolling Sharpe ratio of Verify_RP_ULcer compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.

Verify_RP_ULcer provided a 2.67% dividend yield over the last twelve months.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Verify_RP_ULcer. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Verify_RP_ULcer was 14.28%, occurring on Apr 8, 2025. Recovery took 23 trading sessions.

The current Verify_RP_ULcer drawdown is 2.21%.

The chart below shows the rolling one-month volatility.